Johnson & Johnson (JNJ) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Johnson & Johnson Revenue Highlights

Latest Revenue (Y)

$85.15B

Latest Revenue (Q)

$22.47B

Main Segment (Y)

MedTech

Main Geography (Y)

UNITED STATES

Johnson & Johnson Revenue by Period

Johnson & Johnson Revenue by Year

Date	Revenue	Change
2023-12-31	$85.15B	-10.31%
2023-01-01	$94.94B	1.25%
2022-01-02	$93.78B	13.55%
2021-01-03	$82.58B	0.64%
2019-12-29	$82.06B	0.59%
2018-12-30	$81.58B	6.71%
2017-12-31	$76.45B	6.34%
2017-01-01	$71.89B	2.59%
2016-01-03	$70.07B	-5.73%
2014-12-28	$74.33B	4.23%
2013-12-29	$71.31B	6.08%
2012-12-30	$67.22B	3.37%
2012-01-01	$65.03B	5.59%
2011-01-02	$61.59B	-0.50%
2010-01-03	$61.90B	-2.90%
2008-12-28	$63.75B	4.34%
2007-12-30	$61.09B	14.57%
2006-12-31	$53.32B	5.56%
2006-01-01	$50.51B	6.69%
2005-01-02	$47.35B	13.10%
2003-12-28	$41.86B	15.33%
2002-12-29	$36.30B	9.98%
2001-12-30	$33.00B	13.26%
2000-12-31	$29.14B	6.07%
2000-01-02	$27.47B	16.12%
1999-01-03	$23.66B	4.54%
1997-12-28	$22.63B	4.67%
1996-12-31	$21.62B	14.74%
1995-12-31	$18.84B	19.75%
1995-01-01	$15.73B	11.29%
1994-01-02	$14.14B	-

Johnson & Johnson generated $85.15B in revenue during NA 2023, up -10.31% compared to the previous quarter, and up 104.38% compared to the same period a year ago.

Johnson & Johnson Revenue by Quarter

Date	Revenue	Change
2024-09-28	$22.47B	0.11%
2024-06-30	$22.45B	4.98%
2024-03-31	$21.38B	-0.06%
2023-12-31	$21.39B	0.21%
2023-10-01	$21.35B	-0.78%
2023-07-02	$21.52B	2.99%
2023-04-02	$20.89B	-11.86%
2023-01-01	$23.71B	18.55%
2022-10-02	$20.00B	-16.75%
2022-07-03	$24.02B	2.54%
2022-04-03	$23.43B	-5.56%
2022-01-02	$24.80B	6.28%
2021-10-03	$23.34B	0.11%
2021-07-04	$23.31B	4.44%
2021-04-04	$22.32B	-0.69%
2021-01-03	$22.48B	6.61%
2020-09-27	$21.08B	14.98%
2020-06-28	$18.34B	-11.38%
2020-03-29	$20.69B	-0.27%
2019-12-29	$20.75B	0.09%
2019-09-29	$20.73B	0.81%
2019-06-30	$20.56B	2.70%
2019-03-31	$20.02B	-1.83%
2018-12-30	$20.39B	0.23%
2018-09-30	$20.35B	-2.31%
2018-07-01	$20.83B	4.10%
2018-04-01	$20.01B	-0.92%
2017-12-31	$20.20B	2.77%
2017-10-01	$19.65B	4.30%
2017-07-02	$18.84B	6.04%
2017-04-02	$17.77B	-1.88%
2017-01-01	$18.11B	1.60%
2016-10-02	$17.82B	-3.58%
2016-07-03	$18.48B	5.72%
2016-04-03	$17.48B	-1.85%
2016-01-03	$17.81B	4.15%
2015-09-27	$17.10B	-3.85%
2015-06-28	$17.79B	2.38%
2015-03-29	$17.37B	-4.82%
2014-12-28	$18.25B	-1.15%
2014-09-28	$18.47B	-5.27%
2014-06-29	$19.50B	7.62%
2014-03-30	$18.11B	-1.31%
2013-12-29	$18.36B	4.44%
2013-09-29	$17.57B	-1.69%
2013-06-30	$17.88B	2.13%
2013-03-31	$17.50B	-0.30%
2012-12-30	$17.56B	2.97%
2012-09-30	$17.05B	3.50%
2012-07-01	$16.48B	2.08%
2012-04-01	$16.14B	-0.71%
2012-01-01	$16.25B	1.56%
2011-10-02	$16.00B	-3.57%
2011-07-03	$16.60B	2.62%
2011-04-03	$16.17B	3.38%
2011-01-02	$15.64B	4.42%
2010-10-03	$14.98B	-2.27%
2010-07-04	$15.33B	-1.93%
2010-04-04	$15.63B	-5.56%
2010-01-03	$16.55B	9.75%
2009-09-27	$15.08B	-1.04%
2009-06-28	$15.24B	1.42%
2009-03-29	$15.03B	-1.03%
2008-12-28	$15.18B	-4.64%
2008-09-28	$15.92B	-3.22%
2008-06-29	$16.45B	1.58%
2008-03-30	$16.19B	1.49%
2007-12-30	$15.96B	-

Johnson & Johnson generated $22.47B in revenue during Q3 2024, up 0.11% compared to the previous quarter, and up 104.42% compared to the same period a year ago.

Johnson & Johnson Revenue Breakdown

Johnson & Johnson Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Jan 23	Jan 22	Jan 21	Dec 19
MedTech	$30.40B	$27.43B	-	-	-
Pharmaceutical	-	$52.56B	-	-	-
Consumer	-	$14.95B	$14.63B	$14.05B	$13.90B

Johnson & Johnson's latest annual revenue breakdown by segment (product or service), as of Dec 23: MedTech (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20	Mar 20	Dec 19
MedTech	$7.89B	$7.96B	$7.82B	$7.67B	$7.46B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Medical Devices	-	-	-	-	-	$7.79B	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumer	-	-	-	-	-	$4.01B	$3.85B	$3.77B	$3.79B	$3.81B	$3.59B	$3.66B	$3.70B	$3.73B	$3.54B	$3.62B	$3.51B	$3.30B	$3.63B	$3.57B
Pharmaceutical	-	-	-	-	-	$13.73B	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Johnson & Johnson's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: MedTech (100.00%).

Johnson & Johnson Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Jan 23	Jan 22	Jan 21	Dec 19
Asia-Pacific, Africa	$13.76B	$16.79B	$17.27B	$15.14B	$15.55B
Western Hemisphere, excluding U.S.	$4.55B	$6.13B	-	-	-
UNITED STATES	$46.44B	$48.58B	$47.16B	$43.13B	$42.10B
Europe	$20.41B	$23.45B	$23.59B	$18.98B	$18.47B

Johnson & Johnson's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (54.54%), Europe (23.97%), Asia-Pacific, Africa (16.15%), and Western Hemisphere, excluding U.S. (5.34%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Oct 23	Jul 23	Apr 23	Oct 22	Jul 22	Apr 22	Oct 21	Jul 21	Apr 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Europe	$4.91B	$5.21B	$5.16B	$4.73B	$5.89B	$6.33B	$5.52B	$6.08B	$6.02B	$5.59B	$5.67B	$5.41B	$4.82B	$4.06B	$4.83B	$4.46B	$4.73B	$4.61B	$4.42B	-
Asia-Pacific, Africa	$3.48B	$3.45B	$3.41B	$3.46B	$4.48B	$4.31B	$4.25B	$4.20B	$4.51B	$4.29B	$4.36B	$4.37B	$3.88B	$3.60B	$3.66B	$3.99B	$3.97B	$3.78B	$3.72B	-
Western Hemisphere, excluding U.S.	$1.17B	$1.21B	$1.19B	$1.17B	$1.71B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.06B	-
UNITED STATES	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.48B	-

Johnson & Johnson's latest quarterly revenue breakdown by geography, as of Sep 24: Europe (51.39%), Asia-Pacific, Africa (36.34%), and Western Hemisphere, excluding U.S. (12.27%).

Johnson & Johnson Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
JNJ	Johnson & Johnson	$85.15B	$22.47B
MRK	Merck	$60.12B	$16.66B
PFE	Pfizer	$58.50B	$17.70B
ABBV	AbbVie	$54.32B	$14.46B
BMY	Bristol-Myers Squibb Company	$45.01B	$11.89B
LLY	Eli Lilly and Company	$34.12B	$11.44B
AMGN	Amgen	$28.19B	$8.50B
GILD	Gilead Sciences	$27.12B	$7.55B

JNJ Revenue FAQ

What is Johnson & Johnson’s yearly revenue?

Johnson & Johnson's yearly revenue for 2023 was $85.15B, representing a decrease of -10.31% compared to 2022. The company's yearly revenue for 2022 was $94.94B, representing an increase of 1.25% compared to 2021. JNJ's yearly revenue for 2021 was $93.78B, representing an increase of 13.55% compared to 2020.

What is Johnson & Johnson’s quarterly revenue?

Johnson & Johnson's quarterly revenue for Q3 2024 was $22.47B, a 0.11% increase from the previous quarter (Q2 2024), and a 5.25% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $22.45B, a 4.98% increase from the previous quarter (Q1 2024), and a 4.31% increase year-over-year (Q2 2023). JNJ's quarterly revenue for Q1 2024 was $21.38B, a -0.06% decrease from the previous quarter (Q4 2023), and a 2.34% increase year-over-year (Q1 2023).

What is Johnson & Johnson’s revenue growth rate?

Johnson & Johnson's revenue growth rate for the last 3 years (2021-2023) was -9.20%, and for the last 5 years (2019-2023) was 3.77%.

What are Johnson & Johnson’s revenue streams?

Johnson & Johnson's revenue streams in c 23 are MedTech

What is Johnson & Johnson’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Johnson & Johnson was MedTech. This segment made a revenue of $30.4B, representing 100.00% of the company's total revenue.